Gavin Reynolds is Honorary Professor in the Biomolecular Sciences Research Centre at Sheffield Hallam University and Professor Emeritus, formerly Chair of Neuroscience, at Queen’s University Belfast. He also has an honorary research position at Rotherham, Doncaster and South Humber NHS Trust. After a biochemistry PhD, he undertook postdoctoral work in London, also spending approximately 18 months working in Vienna, moving in 1982 to Cambridge where he supervised the MRC Brain Bank. In 1985 he took up a Wellcome Lectureship at the University of Nottingham, moving in 1990 to the University of Sheffield and in 2004 to take up the Chair of Neuroscience in the Dept of Psychiatry at Queen’s University Belfast.
His main research interests lie in two directions: the neurotransmitter pathology of schizophrenia, and the mechanisms underlying the beneficial and adverse effects of antipsychotics and other psychoactive drugs, with a recent focus on pharmacogenetic and epigenetic influences. Additional interests include neurodegenerative disease mechanisms and biological effects of substance abuse. He has well over 300 research publications, with an h-index of 84.
He has international collaborations with Visiting Professor appointments at universities in Thailand and China. He is a past president of the British Association for Psychopharmacology.
by restoring the activity of mutated proteins. Since October 2012-2018, he has been Master of Gonville and Caius College, Cambridge. Knighted in 2003 for his work on protein science, and has honorary degrees from Uppsala, Brussels, Weizmann Institute, Imperial College and The Hebrew University. He has honorary professorships in China in Shanghai, Chengdu and Qingdao. He has world-wide experience in the needs of science and biotechnology.